Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National ...

Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is ...

Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is ...

There is no strong evidence that replenishing hormones after menopause is linked to dementia, according to a sweeping ...